Results 151 to 160 of about 4,944 (197)

"Look What the Cat Dragged In": Delayed-Onset Hypersensitivity Pneumonitis Due to Pregnancy. [PDF]

Cureus
Roberts R, Rowles A, Alachkar H, Kilduff C.   +3 more
europepmc   +1 more source

Spontaneous Endometrioma Rupture: A Retrospective Pilot Study and Literature Review of a Rare and Challenging Condition. [PDF]

J Clin Med
Kolovos G, Dedes I, Dragusha S, Vaineau C, Mueller M.   +4 more
europepmc   +1 more source

Contraceptive use in France in 2012 and 2022: a descriptive analysis of two repeated nationwide cross-sectional studies. [PDF]

Lancet Reg Health Eur
Poncet L, Roland N, Fortuna R, Hider-Mlynarz K, Dray-Spira R, Weill A, Zureik M.   +6 more
europepmc   +1 more source

Lamotrigine, Contraceptives, and Psychiatry: A Narrative Review. [PDF]

Cureus
Costa I, Esteves-Sousa D.
europepmc   +1 more source

Hormonal contraceptive drug use trends in the Estonian Biobank

Džigurski J, Möls M, Läll K, Currant H, Eltermaa M, Estonian Biobank Research Team, Mägi R, Milani L, Laisk T.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pharmacokinetics of desogestrel

American Journal of Obstetrics and Gynecology, 1993
A synthetic form of desogestrel, a gonane progestin, was developed because desogestrel's enhanced selectivity eliminates adverse, androgen-dependent, metabolic effects at contraceptive doses. Desogestrel is rapidly and completely metabolized in the liver and gut wall to 3-keto-desogestrel, which is the active metabolite mediating the progestin effects.
H D, McClamrock, E Y, Adashi
openaire   +2 more sources

Desogestrel

Clinical Obstetrics and Gynecology, 1995
Desogestrel is a new, potent progestogen with very low androgenic properties. When used as a contraceptive, it is a strong antiovulatory compound, even at low doses. The clinical efficacy is as good as that of the old progestogens. It has a low incidence of side effects and complications, similar to other progestogens.
openaire   +2 more sources